Naphthalene

Naphthalene

SCHEMBL699808

C[C@H](N)C(=O)O.c1ccc2ccccc2c1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.46
ALPI P09923 1/20 0.45
PKM P14618 1/20 0.45
PTGS1 P23219 1/20 0.45
XIAP P98170 1/20 0.45
SLC7A5 Q01650 1/20 0.45
EPHX1 P07099 1/20 0.44
PTGS2 P35354 1/20 0.43
KDM4E B2RXH2 2/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2C P18825 1/20 0.43
LMNA P02545 1/20 0.43
HIF1A Q16665 1/20 0.43
CYP2D6 P10635 2/20 0.42
SRC P12931 1/20 0.42
ALDH1A1 P00352 2/20 0.42
ELANE P08246 1/20 0.42
CYP1A2 P05177 1/20 0.42
CTRB1 P17538 2/20 0.42
PRNP P04156 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Naphthalene SCHEMBL699807 1.00 TAAR1 (0.46) TAAR1ALPIPKMPTGS1XIAP
Anthracene SCHEMBL29064584 0.89 EPHX1 (0.44) TAAR1ALPIPKMPTGS1XIAP
Biphenyl SCHEMBL157604 0.85 TAAR1 (0.60) TAAR1ALPIPKMPTGS1XIAP
Biphenyl SCHEMBL341377 0.85 TAAR1 (0.60) TAAR1ALPIPKMPTGS1XIAP
Alanine SCHEMBL28161213 0.85 CYP1A2 (0.40) TAAR1ALPIPKMPTGS1XIAP
Phenazine SCHEMBL28705329 0.84 ALDH1A1 (0.50) PTGS2KDM4EALDH1A1ELANECTRB1
Pyrene SCHEMBL4782088 0.84 KMT2A (0.50) TAAR1XIAPKDM4ELMNAHIF1A
Alanine SCHEMBL21616532 0.84 SLC7A5 (0.53) TAAR1ALPIPKMPTGS1XIAP
Alanine SCHEMBL27615995 0.84 SLC7A5 (0.53) TAAR1ALPIPKMPTGS1XIAP
Phenol SCHEMBL2786796 0.83 CA12 (0.52) TAAR1ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423223-B1 NOVEL EXENDIN VARIANT AND CONJUGATE THEREOF PEGBIO CO LTD (CN) 2015-04-15 EP disclosed
US-8575097-B2 Exendin variant and conjugate thereof PEGBIO CO., LTD. (CN) 2013-11-05 US disclosed
US-20120196795-A1 NOVEL EXENDIN VARIANT AND CONJUGATE THEREOF PEGBIO CO., LTD. (CN) 2012-08-02 US disclosed
EP-2423223-A1 NOVEL EXENDIN VARIANT AND CONJUGATE THEREOF Pegbio Co., Ltd. (CN) 2012-02-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196795-A1 NOVEL EXENDIN VARIANT AND CONJUGATE THEREOF GLP1R, IAPP, GIPR TAAR1 4541/4885ALPI 2755/4885PKM 2076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.